Jul 6▼ RSI OverboughtRSI 72.4, above 70, stock may be overbought
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. Valued at $74.40B, CL is a large-cap name in its sector. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.
Premium feature
News & analytics is part of Premium.
Every headline runs through our finance-grade sentiment engine, so you see the mood of the market on each ticker before you read a single article. Plus the full analyst consensus and target-price upside, refreshed daily.
Per-headline sentiment, scored by a finance-tuned model
See exactly where the price sits versus its 150-day moving average, the live RSI reading, MACD momentum, and volume context, for any ticker, every day.
Colgate-Palmolive Company carries $7.97B in total debt against $1.42B in cash reserves — debt is roughly 5.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $3.32B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 363.6%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 16.1% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $17.97B to $20.38B.
CL's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Colgate-Palmolive Company and its sector.